Insights

Early market need Small private company with a life-saving cardiac support device targeting hospital cardiac arrest scenarios, presenting a clear mission to address high mortality and a potential for rapid adoption if proven effective.

Strategic partnerships Potential sales opportunities lie in partnering with major medical device players or hospitals for validation studies, surgical adoption, and integration into existing acute care reperfusion and transplant pathways.

Clinical validation Engage in clinical advisory and investigator-led trials to build evidence on bridging to surgery or transplant, leveraging the advisory board appointment to accelerate credibility with buyers.

Crossing the chasm Focus on institutions with high-volume cardiac arrest or circulatory support needs; emphasize time-to-therapy advantages of a pneumatic single-use device to shorten response and improve survival outcomes.

Funding and scale Leverage modest funding and revenue runway to pursue tiered pilots with select hospitals, highlighting cost-benefit and potential outcomes improvements to attract larger OEM partnerships or investors.

Similar companies to MyoCardioCare, Inc.

MyoCardioCare, Inc. Tech Stack

MyoCardioCare, Inc. uses 8 technology products and services including Google Cloud CDN, Joomla, Wix, and more. Explore MyoCardioCare, Inc.'s tech stack below.

  • Google Cloud CDN
    Content Delivery Network
  • Content Management System
  • Content Management System
  • Infrastructure As A Service
  • RequireJS
    Javascript Frameworks
  • Zepto
    Javascript Libraries
  • HSTS
    Security
  • Bootstrap
    UI Frameworks

MyoCardioCare, Inc.'s Email Address Formats

MyoCardioCare, Inc. uses at least 1 email format:
MyoCardioCare, Inc. Email FormatsExamplePercentage
First@myocardiocare.comJohn@myocardiocare.com
100%

Frequently Asked Questions

What is MyoCardioCare, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
MyoCardioCare, Inc.'s official website is myocardiocare.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does MyoCardioCare, Inc. generate?

Minus sign iconPlus sign icon
As of September 2026, MyoCardioCare, Inc.'s annual revenue is estimated to be <$1M.

What is MyoCardioCare, Inc.'s NAICS code?

Minus sign iconPlus sign icon
MyoCardioCare, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does MyoCardioCare, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2026, MyoCardioCare, Inc. has approximately 4 employees across 2 continents, including North America and Asia. Key team members include Co-Founder: S. S. Explore MyoCardioCare, Inc.'s employee directory with LeadIQ.

What industry does MyoCardioCare, Inc. belong to?

Minus sign iconPlus sign icon
MyoCardioCare, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does MyoCardioCare, Inc. use?

Minus sign iconPlus sign icon
MyoCardioCare, Inc.'s tech stack includes Google Cloud CDN, Joomla, Wix, Google Cloud, RequireJS, Zepto, HSTS and Bootstrap.

What is MyoCardioCare, Inc.'s email format?

Minus sign iconPlus sign icon
MyoCardioCare, Inc.'s email format typically follows the pattern of First@myocardiocare.com. Find more MyoCardioCare, Inc. email formats with LeadIQ.

How much funding has MyoCardioCare, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2026, MyoCardioCare, Inc. has raised $25K in funding. The last funding round occurred on Jan 02, 2018 for $25K.
MyoCardioCare, Inc. logo

MyoCardioCare, Inc.

Medical Equipment ManufacturingUnited States2-10 Employees

MyoCardioCare, Inc. is a privately held medical device company based in the United States that was founded in 2009 to advance a novel heart-support technology. The firm is developing a single-use, pneumatically powered device designed to rhythmically compress and expand the heart in order to restore and maintain circulation during cardiac arrest, with the goal of providing a bridge to more definitive therapies such as surgery or transplant. Target customers are healthcare providers treating patients experiencing acute circulatory failure, where existing interventions may be ineffective or slow, and the device aims to improve outcomes by offering timely circulatory support. The company operates within the medical equipment manufacturing industry and is positioned as a developer of life-saving acute circulatory support systems, leveraging early prototypes and research from academic settings to inform its approach. A recent development noted is the appointment of Dr. Brian Gibler to its Scientific Advisory Board in May 2018, reflecting ongoing scientific collaboration as it advances toward commercialization.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $25K

    MyoCardioCare, Inc. has raised a total of $25K of funding over 1 rounds. Their latest funding round was raised on Jan 02, 2018 in the amount of $25K as a Venture Round.

  • <$1M

    MyoCardioCare, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.